Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients.
about
Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosisC-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewC-Reactive Protein and Breast Cancer: New Insights from Old MoleculeMolecular serum portraits in patients with primary breast cancer predict the development of distant metastasesIl-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migrationTumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundanceInactivation of the transcription factor GLI1 accelerates pancreatic cancer progression.Reduced interleukin-17 and transforming growth factor Beta levels in peripheral blood as indicators for following the course of bladder cancerEffect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients ('CHOICE'): study protocol.Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients.Gender difference in the prognostic role of interleukin 6 in oral squamous cell carcinoma.Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model.Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal typeMonocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy.Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells.Evaluation of IL-6 and High Sensitive C Reactive Protein Value in CSF and Serum Children Suspected Meningitis Referred to Pediatric Emergency Room.Significance of Interleukin-6 in Papillary Thyroid Carcinoma.Reduced levels of T-helper 17-associated cytokines in the serum of patients with breast cancer: indicators for following the course of disease.Systemic inflammatory response syndrome in a patient diagnosed with high grade inflammatory triple negative breast cancer: a case report of a potentially rare paraneoplastic syndromeCrevicular fluid and serum concentrations of progranulin and high sensitivity CRP in chronic periodontitis and type 2 diabetes.Postdiagnosis C-reactive protein and breast cancer survivorship: findings from the WHEL studyUnderstanding the link between the IL-6 cytokine family and pregnancy: implications for future therapeutics.Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence.C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression.Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression.An Approach to Breast Cancer Immunotherapy: The Apoptotic Activity of Recombinant Anti-Interleukin-6 Monoclonal Antibodies in Intact Tumour Microenvironment of Breast Carcinoma.Clinical utility of certain biomarkers as predictors of breast cancer with or without metastasis among Egyptian females.Every exercise bout matters: linking systemic exercise responses to breast cancer control.Potential effects of omega-3 fatty acids on anemia and inflammatory markers in maintenance hemodialysis patients.Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis.Quantitation of Vascular Endothelial Growth Factor and Interleukin-6 in Different Stages of Breast Cancer.Gold-nanopatterned single interleukin-6 sandwich immunoassay chips with zeptomolar detection capability based on evanescent field-enhanced fluorescence imaging.Targeting bromodomain and extraterminal proteins in breast cancer.Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer.Autotaxin upregulated by STAT3 activation contributes to invasion in pancreatic neuroendocrine neoplasmsAssociation between the Dietary Inflammatory Index and Risk for Cancer Recurrence and Mortality among Patients with Breast Cancer
P2860
Q26741263-168A8E72-C5A9-4ECF-8F15-3037CB680CA0Q26771557-EF0870B5-269B-4C39-A96A-C7895BE3100BQ26773592-5A0E8EAC-D1FE-4FE1-81DD-CCC7C928FF33Q30503693-CDC52AF4-CDDD-4428-9672-F8E3272A1E30Q30660919-B91DD10D-0917-4E3E-AE75-853193902685Q33662759-73914934-BA9B-4FDB-92D1-163A2E21E499Q33718581-63795984-83F3-4BE7-B469-6824C867984FQ33838828-49F983B1-9562-413E-A4E1-752F9548E9EEQ33953061-0FF519A3-7CC1-46C3-9F3D-21844A37B60AQ34395838-2F72906D-5213-43BB-91B5-C2FD0B519E27Q34491048-5B1E2F37-C638-4C6D-B322-5E4FB85766E6Q34646864-5930DD14-BFB3-468A-9279-46F71E71A100Q34749502-1410C399-9A3E-436D-913C-0B4D8F408046Q35106460-0DA845D0-AE56-4A86-A69B-2796CBA18E8AQ36024587-9040B35D-5D50-49A5-A73B-73BDE6A17DBEQ36546008-CBC28481-C548-4779-A9F6-3991AC4F4C7CQ36655559-194BB023-4012-44CD-A747-4D31E69985A0Q36731164-6CDE3B8B-9EF2-4212-A7BF-684FB9E32D09Q36793048-1AA991AE-BF75-4322-BD25-5350FA3237D5Q37031013-11455EF8-AF9C-4874-B346-73EC6C8FDAADQ37259099-B2E87374-DC7A-47D4-98C0-A0EF4D602870Q37548324-739E11DF-CF94-4A31-B14A-1712145A1CFEQ37927076-477CBD6B-4BFC-4F7D-81BF-DCDC3A9BDE1BQ38197678-B540327E-0CA1-48F1-8790-95F1D9A57C16Q38399277-C65F97E1-BA52-4FDC-A81F-151F7A796798Q38447666-8475AAD3-CFB4-46A9-9F27-70740DF8ADEDQ38786771-73620630-12A2-4484-B451-2AFC57160009Q38863907-C5E45A9B-A0D3-4D22-AB08-45F4AE955DCDQ39110788-4DAF4EA6-FCA1-42A5-B9E7-A743ED28120CQ39278083-85D27731-D13C-430E-9C35-EEF8922FA041Q41470915-345E877B-3B77-4369-9FDF-8EF0D95502B4Q43055486-7D03CCCB-6B6C-4557-8CB8-5398C35D796FQ45151381-C3E69334-A223-44D2-9483-87FACB951F48Q47385983-976CBB15-2CB2-4D71-8818-7C491771396EQ51055057-022057C0-9974-4B3D-9A80-272C33330662Q51068200-1A387392-CEF6-4F15-B2B8-12EB4627A3D0Q57818887-20450636-262A-48FA-B142-41064DE8D96BQ58776754-EEA5F8FA-609E-4ABD-8DA4-FEC767DB121B
P2860
Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical significance of preop ...... vel in breast cancer patients.
@ast
Clinical significance of preop ...... vel in breast cancer patients.
@en
Clinical significance of preop ...... vel in breast cancer patients.
@nl
type
label
Clinical significance of preop ...... vel in breast cancer patients.
@ast
Clinical significance of preop ...... vel in breast cancer patients.
@en
Clinical significance of preop ...... vel in breast cancer patients.
@nl
prefLabel
Clinical significance of preop ...... vel in breast cancer patients.
@ast
Clinical significance of preop ...... vel in breast cancer patients.
@en
Clinical significance of preop ...... vel in breast cancer patients.
@nl
P2860
P356
P1476
Clinical significance of preop ...... vel in breast cancer patients.
@en
P2093
Praveen Ravishankaran
R Karunanithi
P2860
P2888
P356
10.1186/1477-7819-9-18
P577
2011-02-06T00:00:00Z
P5875
P6179
1000521076